期刊文献+

乳酸脱氢酶和C-反应蛋白在基层医院小儿重症支原体肺炎诊治中的应用 被引量:12

Application of LDH and CRP in the diagnosis and treatment of severe mycoplasmal pneumonia in children at primary hospitals
下载PDF
导出
摘要 目的探讨乳酸脱氢酶(LDH)、C-反应蛋白(CRP)在基层医院小儿重症支原体肺炎诊的临床价值。方法选取2016年6月至2018年6月我院收治的的支原体肺炎患儿80例,依据病情程度分为轻症组和重症组各40例。所有患儿给予阿奇霉素10 mg/(kg.d),连续用药3天,停药4天后视病情继续给予阿奇霉素治疗,重症支原体肺炎组在常规治疗的基础上予以糖皮质激素治疗。比较轻症组与重症组治疗前后的LDH、CRP水平。结果重症组患儿治疗后LDH、CRP水平均较治疗前明显降低(P<0.05),且LDH、CRP水平明显高于轻症组(P<0.05)。结论LDH、CRP可作为基层医院小儿重症支原体肺炎诊治的有效指标,适用于基层医院。 Objective To investigate the clinical value of lactate dehydrogenase(LDH)and C-reactive protein(CRP)in the diagnosis of severe mycoplasmal pneumonia in children at primary hospitals.Methods In this study,80 children with mycoplasmal pneumonia in our hospital from June 2016 to June 2018 were selected.According to the severity of the disease,the sick children were divided into mild and severe groups,40 in each group.All sick children were treated with azithromycin 10 mg/(kg.d)and continuous medication for 3 days.Depending on the conditions,azithromycin might be continued after 4 days of withdrawal.Patients with severe mycoplasmal pneumonia were treated with glucocorticoids based on conventional treatment.The levels of LDH and CRP before and after treatment were compared between the two groups.Results Compared with before treatment,the LDH and CRP levels in the severe group were significantly reduced(P<0.05).The levels of LDH and CRP in the severe group were significantly higher than those in the mild group(P<0.05).Conclusion LDH and CRP can be used as effective indicators for the diagnosis and treatment of severe mycoplasmal pneumonia in children in primary hospitals.The two indexes are suitable for primary hospitals.
作者 邓黎明 李君 官燕 DENG Li-ming;LI Jun;GUAN Yan(Departments of Pediatrics,Chengdu Tianfu New District People's Hospital,Chengdu 610213,China)
出处 《实用医院临床杂志》 2019年第5期173-175,共3页 Practical Journal of Clinical Medicine
关键词 乳酸脱氢酶 C-反应蛋白 基层医院 小儿重症支原体肺炎 LDH CRP Primary hospital Pediatric severe mycoplasmal pneumonia
  • 相关文献

参考文献9

二级参考文献105

  • 1谭永龙.儿童肺炎支原体肺炎治疗的研究进展[J].中国科技期刊数据库 医药,2016(9):316-317. 被引量:2
  • 2郝丽,郑成中.支原体肺炎患儿D-二聚体、免疫功能变化及其意义[J].中国生化药物杂志,2014,34(3):156-159. 被引量:34
  • 3饶小春,刘玺诚,江沁波,姜英,马渝燕.儿童支原体肺炎的纤维支气管镜诊治研究[J].中国实用儿科杂志,2007,22(4):264-265. 被引量:71
  • 4温大科,陈灏健,谢娟娟.肺炎支原体肺炎与细菌性肺炎患儿心肌酶变化比较的意义[J].中国优生与遗传杂志,2007,15(7):17-18. 被引量:6
  • 5Tamura A, Matsubara K, Tanaka T, et al. Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children [ J ]. J Infect, 2008, 57 ( 3 ) : 223-228. DOI : 10. 1016/ j. jinf. 2008.06. 012.
  • 6Miyashita N, Kawai Y, Inamura N, et al. Setting a standard for the initiation of steroid therapy in refractory or severe Mycoplasma pneumoniae pneumonia in adolescents and adults [ J ]. J Infect Chemother, 2015, 21 ( 3 ) : 153-160. DOI: 10. 1016/j. jiac. 2014.10. 008.
  • 7Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults[J]. Clin Infect Dis, 2007, 44 Suppl 2: $27-72.
  • 8Tagliabue C, Salvatore CM, Techasaensiri C, et al. The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection [ J]. J Infect Dis, 2008, 198 (8) :1180-1188. DOI: 10. 1086/591915.
  • 9Guo L, Liu F, Lu MP, et al. Increased T cell activation in BALF from children with Mycoplasma pneumoniae pneumonia [ J ]. Pediatr Pulmonol, 2015, 50(8) :814-819. DOI: 10. 1002/ppul. 23095.
  • 10Matsubara K, Morozumi M, Okada T, et al. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients [ J ]. J Infect Chemother, 2009, 15 ( 6 ) : 380-383. DOI: 10. 1007/ s10156-009-0715-7.

共引文献210

同被引文献166

引证文献12

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部